생명공학제품과 관련된 이해관계자 압력과 시장접근성

목차 (Table of Contents)

• Ⅰ. 서론
• Ⅱ. 이론적 배경 및 가설설정
• Ⅲ. 변수측정 및 자료수집
• Ⅳ. 실증분석 및 결과해석
• Ⅴ. 결론 및 시사점
• 참고문헌
• ABSTRACT

참고문헌 (Reference)

1 바이오산업연구회, "현대의 바이오기술과 바이오산업" 도서출판 아카데미서적 1997

2 신한종합연구소, "알기 쉬운 바이오산업" 2000

3 성봉석, "생명공학제품의 시장접근 가능성-유전자변형 농산물 및 식품을 중심으로" 무역학회지 29 (29): 2004

4 장호민, "빈곤과 가난, 그리고 생명공학기술" 한국생명공학연구원 2005

5 Daniell. M. H, "Word of Risks: Next Generation Strategy for a Volatile Era" John Wiley Singapore 2000

6 Kalaitzandonakes. N, "Who is driving biotechnology acceptance?" 21 : 2003

7 Ketchen. D. J, "The application of cluster analysis in strategic management research: an analysis and critique" 17 (17): 1996

8 Babinard. J, "The Stakeholders and the Struggle for Public Opinion, Regulatory Control and Market Development" Press London UK 2001

9 Donaldson. T, "The Stakeholder Theory of the Corporation : Concept, Evidence and Implication" 20 (20): 1995

10 Sharfman. M, "The Next Step in Becoming ‘Green’: Life-Cycle Orineted Environmental Management" Business Horizons 1997

11 Oliver. C, "The Influence of Institutional and Task Environment Relationships on Organizational Performance: The Canadian Construction Industry" 34 (34): 1997

12 Massey A, "The Editors' and Reporters' Guide to Biotechnology Biotechnology Industry Organization" Washington D.C. Blue House Publishing 2004

13 Porter. M, "The Competitive Advantage of Nations" The Free press New York 1990

14 Sharma. S, "The Biotechnology Industry and Strategies of Biodiversity Conservation: The Influence of Managerial Interpretations and Risk Propensity" Business strategy and the Environment 1999

15 Aerni. P, "Public Policy Responses to Biotechnology" Harvard University Cambridge MA 2001

16 Ostlund. L. E, "Perceived Innovation Attributes as Predictors of Innovativeness" 1974

17 Doh. J. P, "Nongovernmental organizations as institutional actors in international business: theory and implications" 11 : 2002

18 Greenley. G. E, "Multiple Stakeholder Orientation in UK Companies and The Implications for Company Performance" 34 (34): 1997

19 Brammer. M, "Monsanto & Genetic Engineering Risks for Investers" Innovest Strategic Value Advisors. Inc. New york. NY 10036 USA 2003

20 Unnevehr. L, "Market Responses to Consumer Demand and Regulatory Change" New York Academic Press 2001

21 Carter C. A, "Mandatory Labelling of Genetically Modified Foods: Does it Really Provide Consumer Choice?" 16 (16): 2003

22 Day. G. S, "Managerial Representations of Competitive Advantage" 58 : 1994

23 Thomas. J. B, "Interpreting strategic issues: effects of strategy and the information processing structure of top management teams" Academy of Management Journal 1990

24 Zarrilli. S, "International Trade in GMOs and GM Products: National and Multilateral Legal Frameworks" UN. New York and Geneva. (29) : 2005

25 Fineman. S, "Green Stakeholders : Industry Interpretations and Response" 33 (33): 1996

26 Orson J, "Gene stacking in herbicide tolerant oilseed rape: lesssons from the North American experience" Peterborough USA (443) : 2002

27 Burke. D, "GM food and Crops: what went wrong in the UK?-Manyof the public's concerns have little to do with science" European Molecular Biology Organization 5 (5): 2004

28 Burke. D, "GM food and Crops: what went wrong in the UK?-Many of the public's concerns have little to do with science" European Molecular Biology Organization 5 (5): 2004

29 Spriggs. J, "Food Safety and International Competitiveness: the Case of Beef" CAB International. Wallingford. UK 2001

30 Barney. J. B, "Firm Resources and Sustained Competitive Advantage" 17 (17): 1991

31 Frewer. L. J, "Ethical concerns and risk perceptions associated with different applications of genetic engineering: Interrelationship with the perceived need for regulation of the technology" 12 : 1995

32 Jackson. S. E, "Discerning threats and opportunities" Administrative Science Quarterly 1988

33 Punj. G, "Cluster analysis in marketing research; review and suggestions for application" 20 : 1983

34 Alderderfer. M. S, "Cluster Analysis" Sage. London. 1984

35 Arundel. A, "Biotechnology Indicators and Public Policy" OECD 2003

36 Huffman. W, "Better Dead than GM-Fed?" Department of Economics Iowa State University 2003

37 Harrigan. K. P, "An application of clustering for strategic group analysis" 6 (6): 1985

38 Waygood. S, "A critical assessment of how non governmental ogaanizations use the capital markets to achieve their aims: a UK study" Business Strategy and the Environment 2003

39 Bruce. D. M, "A Social Contract for Biotechnology: Shared Visions for Risky Technologies?" 15 : 2002

40 Moon. W. K, "A Multi attribute Model of Public Acceptance of Genetically Modified Organisms" Chicago 5-8, 2001